Clinical Trial Update: DOAC in Unusual Site Venous Thrombosis

View source ↗

Summary

A completed clinical trial from the University of Malta evaluated the use of a direct-acting oral anticoagulant (DOAC) for unusual-site venous thrombosis. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Venous Thrombosis
• Ovarian Vein Thrombosis
• Renal Vein Thrombosis
• Retinal Vein Thrombosis
• Splanchnic Vein Thrombosis

Snippet

Sponsor: University of Malta | Conditions: Splanchnic Vein Thrombosis, Cerebral Vein Thrombosis | Status: COMPLETED